Literatura académica sobre el tema "Estrogen Receptor - Cancer Therapeutics"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Estrogen Receptor - Cancer Therapeutics".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Estrogen Receptor - Cancer Therapeutics"
Arterburn, Jeffrey B. y Eric R. Prossnitz. "G Protein–Coupled Estrogen Receptor GPER: Molecular Pharmacology and Therapeutic Applications". Annual Review of Pharmacology and Toxicology 63, n.º 1 (20 de enero de 2023): 295–320. http://dx.doi.org/10.1146/annurev-pharmtox-031122-121944.
Texto completoMitra, Saikat, Mashia Subha Lami, Avoy Ghosh, Rajib Das, Trina Ekawati Tallei, Fatimawali, Fahadul Islam et al. "Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications?" Cancers 14, n.º 3 (1 de febrero de 2022): 759. http://dx.doi.org/10.3390/cancers14030759.
Texto completoMonga, Jyoti, Niladry S. Ghosh, Somdutt Mujwar y Isha Rani. "IN SILICO STUDIES OF SOME NEWLY DESIGNED BENZIMIDAZOLETHIAZOLIDINONE BASED ANTAGONISTS OF HUMAN ESTROGEN RECEPTOR". INDIAN DRUGS 60, n.º 08 (28 de agosto de 2023): 15–30. http://dx.doi.org/10.53879/id.60.08.14087.
Texto completoChang, Minsun, Kuan-wei Peng, Irida Kastrati, Cassia R. Overk, Zhi-Hui Qin, Ping Yao, Judy L. Bolton y Gregory R. J. Thatcher. "Activation of Estrogen Receptor-Mediated Gene Transcription by the Equine Estrogen Metabolite, 4-Methoxyequilenin, in Human Breast Cancer Cells". Endocrinology 148, n.º 10 (1 de octubre de 2007): 4793–802. http://dx.doi.org/10.1210/en.2006-1568.
Texto completoShete, Nivida, Jordan Calabrese y Debra A. Tonetti. "Revisiting Estrogen for the Treatment of Endocrine-Resistant Breast Cancer: Novel Therapeutic Approaches". Cancers 15, n.º 14 (17 de julio de 2023): 3647. http://dx.doi.org/10.3390/cancers15143647.
Texto completoPetrie, Whitney K., Megan K. Dennis, Chelin Hu, Donghai Dai, Jeffrey B. Arterburn, Harriet O. Smith, Helen J. Hathaway y Eric R. Prossnitz. "G Protein-Coupled Estrogen Receptor-Selective Ligands Modulate Endometrial Tumor Growth". Obstetrics and Gynecology International 2013 (2013): 1–17. http://dx.doi.org/10.1155/2013/472720.
Texto completoMedina, Mauricio A., Goldie Oza, Ashutosh Sharma, L. G. Arriaga, José Manuel Hernández Hernández, Vincent M. Rotello y Jose Tapia Ramirez. "Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies". International Journal of Environmental Research and Public Health 17, n.º 6 (20 de marzo de 2020): 2078. http://dx.doi.org/10.3390/ijerph17062078.
Texto completoIde, Hiroki y Hiroshi Miyamoto. "Sex Hormone Receptor Signaling in Bladder Cancer: A Potential Target for Enhancing the Efficacy of Conventional Non-Surgical Therapy". Cells 10, n.º 5 (11 de mayo de 2021): 1169. http://dx.doi.org/10.3390/cells10051169.
Texto completoLucà, Rossella, Giorgia di Blasio, Daniela Gallo, Valentina Monteleone, Isabella Manni, Laura Fici, Marianna Buttarelli et al. "Estrogens Counteract Platinum-Chemosensitivity by Modifying the Subcellular Localization of MDM4". Cancers 11, n.º 9 (12 de septiembre de 2019): 1349. http://dx.doi.org/10.3390/cancers11091349.
Texto completoDi Zazzo, Galasso, Giovannelli, Di Donato, Bilancio, Perillo, Sinisi, Migliaccio y Castoria. "Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer". Cancers 11, n.º 10 (23 de septiembre de 2019): 1418. http://dx.doi.org/10.3390/cancers11101418.
Texto completoTesis sobre el tema "Estrogen Receptor - Cancer Therapeutics"
Jackson, Alexander. "Estradiol based steroid reagents : potential estrogen receptor targeted breast cancer therapeutics and diagnostics". Thesis, University of Warwick, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.248833.
Texto completoJetson, Rachael Rene. "Design and Development of Potential Therapeutic Agents for Use in Hormone Responsive Cancers". University of Toledo Health Science Campus / OhioLINK, 2013. http://rave.ohiolink.edu/etdc/view?acc_num=mco1384270219.
Texto completoHatchell, Esme Claire. "Insight into estrogen action in breast cancer via the study of a novel nuclear receptor corepressor : SLIRP". University of Western Australia. School of Medicine and Pharmacology, 2008. http://theses.library.uwa.edu.au/adt-WU2008.0206.
Texto completoWei, Na. "Oestrogen receptor subtypes in ovarian cancer". Click to view the E-thesis via HKUTO, 2008. http://sunzi.lib.hku.hk/HKUTO/record/B39558058.
Texto completoStewart, Ceri Elisabeth. "Estrogen receptor beta and estrogen response in breast cancer cell lines". Thesis, University of Liverpool, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.491371.
Texto completoCurran, Edward M. "Regulation of the estrogen receptor in human breast cancer cells /". free to MU campus, to others for purchase, 1998. http://wwwlib.umi.com/cr/mo/fullcit?p9901231.
Texto completoZhang, Qiu-Xia. "Estrogen receptor gene alterations in human breast cancer". Lund : Jubileumsinstitutionen, Dept. of Oncology,Lund University, 1997. http://catalog.hathitrust.org/api/volumes/oclc/39738537.html.
Texto completoWei, Na y 魏娜. "Oestrogen receptor subtypes in ovarian cancer". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2008. http://hub.hku.hk/bib/B39558058.
Texto completoChiu, Shih-Jiuan. "Receptor-mediated DNA-based therapeutics delivery". Columbus, Ohio : Ohio State University, 2005. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1127403022.
Texto completoStuart, Emma y n/a. "Therapeutic potential of SERM and EGCG drug combinations for the treatment of basal-like breast cancer". University of Otago. Department of Pharmacology & Toxicology, 2009. http://adt.otago.ac.nz./public/adt-NZDU20090708.090405.
Texto completoLibros sobre el tema "Estrogen Receptor - Cancer Therapeutics"
Craig, Jordan V. y Furr B. J. A, eds. Hormone therapy in breast and prostate cancer. Totowa, N.J: Humana Press, 2002.
Buscar texto completo1944-, Miller William R. y Ingle James N. 1944-, eds. Endocrine therapy in breast cancer. New York: Marcel Dekker, 2002.
Buscar texto completoZhang, Xiaoting, ed. Estrogen Receptor and Breast Cancer. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-99350-8.
Texto completoPower, Krista Anne. Selective estrogen receptor modulators in breast cancer. Ottawa: National Library of Canada, 2002.
Buscar texto completoM, Berstein Lev y Santen Richard J, eds. Innovative endocrinology of cancer. New York: Springer Science+Business Media, 2008.
Buscar texto completoMoelleken, Brent Roderick Wilfred. Tamoxifen - 5-fluorouracil synergy in human breast cancer cell lines: Correlating in vitro synergy with the current estrogen receptor model. [New Haven: s.n.], 1985.
Buscar texto completoYarden, Yosef y Moshe Elkabets, eds. Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-67932-7.
Texto completoMIller/Ingle. Endocrine Therapy in Breast Cancer. Informa Healthcare, 2002.
Buscar texto completo(Editor), James N. Ingle y Mitchell Dowsett (Editor), eds. Endocrine Therapy for Breast Cancer. Informa Healthcare, 2004.
Buscar texto completoEstrogen/antiestrogen action and breast cancer therapy. Madison, Wis: University of Wisconsin Press, 1986.
Buscar texto completoCapítulos de libros sobre el tema "Estrogen Receptor - Cancer Therapeutics"
Leonard, Marissa, Juan Tan, Yongguang Yang, Mahmoud Charif, Elyse E. Lower y Xiaoting Zhang. "Emerging Therapeutic Approaches to Overcome Breast Cancer Endocrine Resistance". En Estrogen Receptor and Breast Cancer, 379–403. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-99350-8_14.
Texto completoMcBryan, Jean y Leonie S. Young. "Ligand-Independent Signalling Through Estrogen Receptor Pathways in Breast Cancer". En Resistance to Targeted Anti-Cancer Therapeutics, 115–44. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-17972-8_7.
Texto completoMir, Manzoor Ahmad y Ulfat Jan. "Cdk4/Cdk6 Dysregulation in Estrogen-Positive Receptor Breast Cancers". En Therapeutic potential of Cell Cycle Kinases in Breast Cancer, 211–32. Singapore: Springer Nature Singapore, 2023. http://dx.doi.org/10.1007/978-981-19-8911-7_10.
Texto completoKlinge, C. M. "Selective Estrogen Receptor Modulators as Therapeutic Agents in Breast Cancer Treatment". En Transcription Factors, 455–90. Berlin, Heidelberg: Springer Berlin Heidelberg, 2004. http://dx.doi.org/10.1007/978-3-642-18932-6_15.
Texto completoLazennec, Gwendal. "Estrogen Receptor". En Encyclopedia of Cancer, 1–5. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-27841-9_2014-2.
Texto completoLazennec, Gwendal. "Estrogen Receptor". En Encyclopedia of Cancer, 1633–36. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-46875-3_2014.
Texto completoLazennec, Gwendal. "Estrogen Receptor". En Encyclopedia of Cancer, 1327–30. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16483-5_2014.
Texto completoChang, Jenny y C. Kent Osborne. "SERMs and Breast Cancer Prevention". En Selective Estrogen Receptor Modulators, 267–78. Totowa, NJ: Humana Press, 2002. http://dx.doi.org/10.1007/978-1-59259-157-2_16.
Texto completoHansen, R. K. y S. A. W. Fuqua. "The Estrogen Receptor and Breast Cancer". En Breast Cancer, 1–30. Totowa, NJ: Humana Press, 1999. http://dx.doi.org/10.1007/978-1-59259-456-6_1.
Texto completoEncarnacion, Carlos A. y Suzanne A. W. Fuqua. "Estrogen receptor variants in breast cancer". En Cancer Treatment and Research, 97–109. Boston, MA: Springer US, 1994. http://dx.doi.org/10.1007/978-1-4615-2592-9_6.
Texto completoActas de conferencias sobre el tema "Estrogen Receptor - Cancer Therapeutics"
Price, Meghan, Catherine Lavau, Cesar Baeta, Jovita Byemerwa, Suzanne Wardell, Olivia Brueckner, Debarati Mukherjee et al. "Abstract P131: The role of UDP-6 glucose dehydrogenase (UGDH) in estrogen-mediated phenotypes in both estrogen receptor positive and estrogen receptor negative breast cancer". En Abstracts: AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics; October 7-10, 2021. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1535-7163.targ-21-p131.
Texto completoCherian, Mathew, Jharna Datta, Mahmoud Kassem, Natalie Willingham, Jasmine Manouchehri, Joel David, Mirisha Sheth et al. "Abstract 5158: Estrogen receptor β agonists: A novel therapeutic strategy for breast cancer". En Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-5158.
Texto completoParashar, Deepak, Anjali Geethadevi, Jyotsna Mishra, Bindu Nair, Bindu Santhamma, Klaus Nickisch y Pradeep Chaluvally-Raghavan. "Abstract A195: A novel selective estrogen receptor degrader, EC-372, inhibits tumor growth and metastasis of breast cancer cells". En Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; October 26-30, 2017; Philadelphia, PA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1535-7163.targ-17-a195.
Texto completoBarlaam, Bernard, Jason Breed, Rodrigo J. Carbajo, Eric Gangl, Samantha Hughes, Christopher J. Morrow, Thomas A. Moss et al. "Abstract A107: Small Molecule Degraders of the Estrogen Receptor (SERDs): Optimization of the tricyclic indole scaffold beyond AZD9496". En Abstracts: AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics; October 26-30, 2019; Boston, MA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1535-7163.targ-19-a107.
Texto completoSingh, Kriti, Ravi SN Munuganti, Miriam Butler, Artem Cherkasov y Paul S. Rennie. "Abstract PD6-7: In-silico discovery of novel estrogen receptor-α inhibitors as potential therapeutics for tamoxifen resistant breast cancer". En Thirty-Seventh Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 9-13, 2014; San Antonio, TX. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.sabcs14-pd6-7.
Texto completoDarimont, Beatrice, Steven Govek, James Joseph, Katherine Grillot, Eric Bischoff, Anna Aparicio, Celine Bonnefous et al. "Abstract A133: A novel class of selective estrogen receptor degraders regresses tumors in preclinical models of endocrine-resistant breast cancer." En Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 12-16, 2011; San Francisco, CA. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1535-7163.targ-11-a133.
Texto completoOkuhira, Keiichiro, Yosuke Demizu, Takayuki Hattori, Nobumichi Ohoka, Norihito Shibata, Tomoko Nishimaki-Mogami, Haruhiro Okuda, Masaaki Kurihara y Mikihiko Naito. "Abstract B255: Development of hybrid small molecules that induce degradation of estrogen receptor-alpha and necrotic cell death in breast cancer cells." En Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Oct 19-23, 2013; Boston, MA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.targ-13-b255.
Texto completoSamayoa, C., NK Krishnegowda, R. Vadlamudi y RR Tekmal. "Abstract P3-04-03: Investigating the therapeutic use of estrogen receptor β agonists in breast cancer". En Abstracts: Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 8-12, 2015; San Antonio, TX. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.sabcs15-p3-04-03.
Texto completoLiang, Yayun y Salman Hyder. "Abstract P139: An estrogen receptor beta agonist liquiritigenin potentiates inhibition of hormone-dependent breast-cancer growth by cholesterol biosynthesis inhibitor RO 48-8071". En Abstracts: AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics; October 7-10, 2021. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1535-7163.targ-21-p139.
Texto completoMeng, Ran, Heng Yuan Tang, Shaker A. Mousa, Mary K. Luidens, Faith B. Davis, Paul J. Davis, Hung Yun Lin y Aleck A. Hercbergs. "Abstract C146: In human lung carcinoma cells that contain estrogen receptor-α(ER), thyroid hormone-induced proliferation initiated at an integrin requires ER." En Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 12-16, 2011; San Francisco, CA. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1535-7163.targ-11-c146.
Texto completoInformes sobre el tema "Estrogen Receptor - Cancer Therapeutics"
Wuttke, Deborah S. Breast Cancer Therapeutics, Environmental Estrogens, and the Estrogen Receptor (ER); Characterization of the Diverse Ligand Binding Properties of the ER. Fort Belvoir, VA: Defense Technical Information Center, julio de 2002. http://dx.doi.org/10.21236/ada408777.
Texto completoWuttke, Deborah S. Breast Cancer Therapeutics, Environmental Estrogens, and the Estrogen Receptor (ER); Characterization of the Diverse Ligand Binding Properties of the ER. Fort Belvoir, VA: Defense Technical Information Center, julio de 2003. http://dx.doi.org/10.21236/ada420485.
Texto completoBurgess, Richard R. Estrogen-Related Receptor Alpha (ERRa)-Coactivator Interactions as Targets for Discovery of New Anti-Breast Cancer Therapeutics. Fort Belvoir, VA: Defense Technical Information Center, marzo de 2006. http://dx.doi.org/10.21236/ada452545.
Texto completoBurgess, Richard R. Estrogen-related Receptor alpha (ERR (alpha))-Coactivator Interactions as Targets for Discovery of New Anti-breast Cancer Therapeutics. Fort Belvoir, VA: Defense Technical Information Center, marzo de 2008. http://dx.doi.org/10.21236/ada572642.
Texto completoBurgess, Richard R. Estrogen-Related Receptor alpha (ERR (alpha))-Coactivator Interactions as Targets for Discovery of New Anti-Breast Cancer Therapeutics. Fort Belvoir, VA: Defense Technical Information Center, marzo de 2007. http://dx.doi.org/10.21236/ada469959.
Texto completoGreene, Geoffrey. Multidomain Assembly of Nuclear Estrogen Receptors: Structural Insights into ER-Positive Breast Cancer Therapeutics. Fort Belvoir, VA: Defense Technical Information Center, abril de 2012. http://dx.doi.org/10.21236/ada562255.
Texto completoGreene, Geoffrey. Multi-Domain Assembly of Nuclear Estrogen Receptors: Structural Insights into ER-Positive Breast Cancer Therapeutics. Fort Belvoir, VA: Defense Technical Information Center, abril de 2013. http://dx.doi.org/10.21236/ada580416.
Texto completoWuttke, Deborah S. Breast Cancer Therapeutics, Environmental Estrogens, and the Estrogens Receptor (ER); Characterization of the Diverse Ligand Binding Properties of the ER. Fort Belvoir, VA: Defense Technical Information Center, julio de 2001. http://dx.doi.org/10.21236/ada398995.
Texto completoGreene, Geoffrey L. Estrogen Receptor Accessory Factors in Breast Cancer Cells. Fort Belvoir, VA: Defense Technical Information Center, agosto de 1998. http://dx.doi.org/10.21236/ada359619.
Texto completoAdami, Hans-Olov G. y Landegran. Estrogen Receptor Gene Polymorphisms and Breast Cancer Risk. Fort Belvoir, VA: Defense Technical Information Center, diciembre de 2000. http://dx.doi.org/10.21236/ada392392.
Texto completo